0 results for 'Cigna'
Event-Driven Securities Litigation: Its Rise and Partial Fall
In his Corporate Securities column, John C. Coffee Jr. writes: Securities litigation is now near an all-time high. Why? It seems to be the product of multiple factors, but two stand out: (1) the migration of “merger objection” cases from Delaware to federal court, and (2) the appearance of a new style of securities litigation that is increasingly called “event-driven” litigation.5 Things Senators Are Hearing About Killer Drug Prices
One sign of the size of the problem is the Cigna-Kroger celecoxib price gap.With Increased Scrutiny, NJ Cases Remind Employers to Review and Update Arbitration Agreements
Recent cases in New Jersey have emphasized that there are several requirements that employers must consider when drafting and enforcing arbitration agreements.Anthem promises transparency in new PBM
The company says its new PBM, IngenioRx,will pass along rebates to customers at the pharmacy counter.Circuit Panel Tosses 'Creative' Securities Class Action Against Cigna
U.S. Circuit Judge José Cabranes, writing for the panel, chided attempts to construe "corporate mismanagement as securities fraud" in affirming the dismissal of a class action against Cigna.Meet the Judge: What to Know About Amy Berman Jackson
Roger Stone must explain why his conditions for release and a media contact order placed on him shouldn't be revoked or changed in light of a photo he posted on Instagram that featured Jackson with a crosshair next to her head.Court Says Pfizer's Emailed Employee Arbitration Agreement Insufficient
The court said companies seeking to institute a mandatory arbitration policy for job-related disputes still must obtain their employees' knowing and explicit assent, even where the policy is disseminated electronically, rather than on paper.US Law Firms Have Strong Year in 2018 Global M&A
But the total number of global deals declined—the first drop since 2010.Shareholder Lawsuit Over Failed Rite Aid-Walgreens Merger Tossed
A federal judge has ruled against a shareholder in a fraudulent misrepresentation lawsuit filed in connection with the aborted merger of the pharmacy chains.Trending Stories
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now